Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
Besides Sun Pharma, a growing roster of Indian drugmakers is gearing up to enter the GLP1 space, lining up generic versions of semaglutide ahead of the patent expiry in March 2026 and tap into the demand: Dr Reddys Laboratories Hyderabadbased Dr Reddys Laboratories has also secured regulatory approval for a generic semaglutide product, receiving DCGI clearance earlier this week to manufacture and sell a generic version of Ozempic for the treatment of type 2 diabetes
Research Jastreboff et al., Triple- Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial, N
Otolaryngol Clin North Am 43(2):229238 Brandfon S, Eylon A, Khanna D, Parmar MS
Oral frailty and its determinants in older age: a systematic review
US$ 27.87
US$ 24.20
US$ 25.82
US$ 27.73
US$ 29.60
US$ 20.96
US$ 20.27
US$ 27.69
